General
Australia’s current COVID-19 treatment options, and why the national death rate is so high
As Australia’s vaccine rollout eases — slowly — into its second phase, experts are pausing to reflect on how far we’ve come with COVID-19 treatments and what the prospects are for saving more lives.
US-based Craig Rayner sits on the World Health Organization’s therapeutics committee for COVID-19.
“From a global view, we started off really with a mad dash to look for anything that we could re-purpose,” said Dr Rayner, who is the president of integrated drug development at the company Certara.
Steven Tong is an infectious disease expert with Australia’s Doherty Institute and one of the principal investigators in a trial gathering evidence on COVID-19 treatments.
He…
-
General22 hours agoVote counting begins for Townsville mayoral by-election
-
General16 hours agoPope Leo XIV urges Hollywood actors to resist algorithms and save neighbourhood cinemas
-
Business14 hours agoNvidia’s quiet move into quantum computing could reshape the next frontier of AI
-
Business13 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
